735 results on '"Lymphoma, Extranodal NK-T-Cell"'
Search Results
2. [ON A CASE OF MALIGNANT RETICULOSIS AT THE BASE OF THE TONGUE].
3. [Malignant histocytic reticulosis of dermo-hypodermic tumor type (reticulosarcoma)].
4. Two cases of malignant reticulosis.
5. [Acute malignant reticulosis].
6. [Subacute malignant histomonocytic reticulosis with predominant laryngeal and cutaneous manifestations].
7. [Malignant reticulosis, multinodular form].
8. [Clinical studies on pseudoleukemic malignant reticulosis].
9. [Paper electrophoresis in malignant reticuloses].
10. [Radiological images in malignant histiomonocytic reticulosis in children].
11. [Malignant histocytic reticulosis of erythematous-squamous (psoriasiform) and ulcerovegetans form].
12. [Pulmonary manifestations during the course of malignant reticulosis in early infancy].
13. [Malignant reticulosis of the skin & stomach; preliminary stage of simple hyperplastic reticulosis over 30 years].
14. [Malignant histiomonocytic reticulosis with tumorous manifestations].
15. [A case of acute malignant histiomonocytary reticulosis].
16. [Cutaneous malignant histiolymphocytic reticulosis with monocytemia and lymphocytemia of the leukemic type].
17. [Malignant reticulosis of the skin].
18. [Case of malignant cutaneous reticulosis (presented in October 1954)].
19. [Malignant histiocytic reticulosis].
20. Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms
21. Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies
22. A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
23. Selinexor, Anti-PD-1 Antibody Plus Golidocitinib in R/R NKTCL
24. Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma
25. Study of Sugemalimab (or Placebo) Plus PGemOx Regimen in Participants With Extranodal NK/T-Cell Lymphoma
26. PET and EBV DNA-directed Therapy for Localized Nasal Extranodal NK/T Cell Lymphoma (ENKTL)
27. Pembrolizumab and Radiotherapy for Patients With NK/T Cell Lymphoma
28. Safety & Efficacy of Peg-ASP-based CCRT in Early Stage ENKTL (ENKTL)
29. Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency
30. B-MAD Chemotherapy in Newly-diagnosed Extranodal NK/ T-cell Lymphoma
31. A Study of IMC-001 in Subjects With Relapsed or Refractory Extranodal NK/T Cell Lymphoma, Nasal Type
32. Concurrent Tislelizumab and Radiotherapy in Newly Diagnosed Extranodal NK/T-cell Lymphoma, Nasal Type
33. Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant
34. Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma
35. CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma
36. Ipilimumab and Local Radiation for Selected Solid Tumors
37. Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma
38. A Registry for People With T-cell Lymphoma
39. Donor Peripheral Stem Cell Transplant in Treating Patients With Hematolymphoid Malignancies
40. Carfilzomib in Treating Patients With Relapsed or Refractory T-Cell Lymphoma
41. Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer
42. Clinical Study of Anti-CD56-CAR-T in the Treatment of Relapsed/Refractory NK/T Cell Lymphoma /NK Cell Leukemia
43. Prognostic Nomogram of Extranodal NK/T-cell Lymphoma
44. A Study of STI-3031 (an Anti-PD-L1 Antibody) in Patients With Selected Relapsed/Refractory Malignancies
45. Phase 1 Study of Autologous CD30.CAR-T in Relapsed or Refractory CD30 Positive Non-Hodgkin Lymphoma (CERTAIN)
46. An Expanded Access Program to Provide Sugemalimab for the Treatment of Relapsed or Refractory Extranodal Natural Killer/T-Cell Lymphoma (R/R ENKTL)
47. Evaluation of Safety and Efficacy of IBI318 Monotherapy for Relapsed/Refractory Extranodal NK/T Cell Lymphoma (Nasal Type) Trial
48. Pegaspargase Combined With Gemcitabine, Etoposide, Liposomal Mitoxantrone Hydrochloride and Dexamethasone (P-GEMD) in the Treatment of Untreated Early Non-upper Respiratory Tract or Advanced Extranodal NK/T-cell Lymphoma
49. T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas
50. A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.